Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 10, 2010, Pages 1545-1556

  Xu, Si Guang ^a   Yan, Pei Jun ^a   Shao, Zhi Ming ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Breast cancer; Mass spectrometry; Metastasis; Two dimensional gel electrophoresis

Indexed keywords

CHLORIDE INTRACELLULAR CHANNEL PROTEIN 1; GALECTIN 1; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; ISOCITRATE DEHYDROGENASE (NADP); ISOFORM 1 OF URIDINE CYTIDINE KINASE 2; MACROPHAGE CAPPING PROTEIN 1; N MYC DOWNSTREAM REGULATED PROTEIN 1; ONCOPROTEIN; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR 2; STATHMIN; STATHMIN 1; TRANSGELIN; TRANSGELIN 2; UNCLASSIFIED DRUG; URIDINE KINASE;

ARTICLE; BREAST CANCER; CANCER CELL; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ELECTROSPRAY MASS SPECTROMETRY; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METASTASIS POTENTIAL; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROTEOMICS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 77956059880     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-010-0812-0     Document Type: Article

References (50)

1. J Ahn M Murphy S Kratowicz A Wang AJ Levine DL George 1999 Down-regulation of the stathmin/Op18 and FKBP25 genes following p53 induction Oncogene 18 5954 5958 10.1038/sj.onc.1202986 1:CAS:528:DyaK1MXnt1ygurg%3D 10557083
2. A Albini Y Iwamoto HK Kleinman GR Martin SA Aaronson JM Kozlowski RN McEwan 1987 A rapid in vitro assay for quantitating the invasive potential of tumor cells Cancer Res 47 3239 3245 1:STN:280:DyaL2s3hsFKhtQ%3D%3D 2438036
3. G Baldassarre B Belletti MS Nicoloso M Schiappacassi A Vecchione P Spessotto A Morrione V Canzonieri A Colombatti 2005 p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion Cancer Cell 7 51 63 10.1016/j.ccr.2004.11.025 1:CAS:528:DC%2BD2MXhsVaitrY%3D 15652749
4. LD Belmont TJ Mitchison 1996 Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules Cell 84 623 631 10.1016/S0092-8674(00)81037-5 1:CAS:528:DyaK28Xhtlemsrc%3D 8598048
5. WP Blackstock MP Weir 1999 Proteomics: quantitative and physical mapping of cellular proteins Trends Biotechnol 17 121 127 10.1016/S0167-7799(98)01245-1 1:CAS:528:DyaK1MXlt1Kjur4%3D 10189717
6. MM Bradford 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 248 254 10.1016/0003-2697(76)90527-3 1:CAS:528: DyaE28XksVehtrY%3D 942051
7. G Brattsand G Roos U Marklund H Ueda G Landberg E Nånberg P Sideras M Gullberg 1993 Quantitative analysis of the expression and regulation of an activation-regulated phosphoprotein (oncoprotein 18) in normal and neoplastic cells Leukemia 7 569 579 1:STN:280:DyaK3s3hvVaktw%3D%3D 8464235
8. PP Budde A Kumagai WG Dunphy R Heald 2001 Regulation of Op18 during spindle assembly in Xenopus egg extracts J Cell Biol 153 149 158 10.1083/jcb.153.1.149 1:CAS:528:DC%2BD3MXisVyhtb8%3D 11285281
9. H Cangul 2004 Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers BMC Genet 5 27 10.1186/1471-2156-5-27 15341671
10. H Cangul K Salnikow H Yee D Zagzag T Commes M Costa 2002 Enhanced overexpression of an HIF-1/hypoxia-related protein in cancer cells Environ Health Perspect 110 783 788 1:CAS:528:DC%2BD38XovFKhsb8%3D 12429530
11. M Christgen U Lehmann 2007 MDA-MB-435: the questionable use of a melanoma cell line as a model for human breast cancer is ongoing Cancer Biol Ther 6 1355 1357 10.4161/cbt.6.9.4624 1:CAS:528:DC%2BD1cXhtlCisbc%3D 17786032
12. PA Curmi C Noguès S Lachkar N Carelle MP Gonthier A Sobel R Lidereau I Bièche 2000 Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours Br J Cancer 82 142 150 10.1054/bjoc.1999.0891 1:CAS:528:DC%2BD3cXltFWktg%3D%3D 10638981
13. E Dahl A Sadr-Nabavi E Klopocki B Betz S Grube R Kreutzfeld M Himmelfarb HX An S Gelling I Klaman B Hinzmann G Kristiansen R Grützmann R Kuner B Petschke K Rhiem K Wiechen C Sers O Wiestler A Schneider H Höfler J Nährig M Dietel R Schäfer A Rosenthal R Schmutzler M Dürst A Meindl D Niederacher 2005 Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancer J Pathol 205 21 28 10.1002/path.1687 1:CAS:528:DC%2BD2MXotFyrug%3D%3D 15586368
14. SJ Ding Y Li YX Tan MR Jiang B Tian YK Liu XX Shao SL Ye JR Wu R Zeng HY Wang ZY Tang QC Xia 2004 From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis Mol Cell Proteomics 3 73 81 1:CAS:528:DC%2BD2cXhtVantLs%3D 14593079
15. TP Ellen Q Ke P Zhang M Costa 2008 NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states Carcinogenesis 29 2 8 10.1093/carcin/bgm200 1:CAS:528:DC%2BD1cXhs1aitr0%3D 17916902
16. G Ellison T Klinowska RF Westwood E Docter T French JC Fox 2002 Further evidence to support the melanocytic origin of MDA-MB-435 Mol Pathol 55 294 299 10.1136/mp.55.5.294 1:CAS:528:DC%2BD38XovFKhu74%3D 12354931
17. JT Feng YK Liu HY Song Z Dai LX Qin MR Almofti CY Fang HJ Lu PY Yang ZY Tang 2005 Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis Proteomics 5 4581 4588 10.1002/pmic.200401309 1:CAS:528:DC%2BD2MXht12nt7vM 16240287
18. B Fisher J Dignam J Bryant N Wolmark 2001 Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial J Natl Cancer Inst 93 684 690 10.1093/jnci/93.9.684 1:CAS:528:DC%2BD3MXjvVamu70%3D 11333290
19. JJ Gildea MJ Seraj G Oxford MA Harding GM Hampton CA Moskaluk HF Frierson MR Conaway D Theodorescu 2002 RhoGDI2 is an invasion and metastasis suppressor gene in human cancer Cancer Res 62 6418 6423 1:CAS:528:DC%2BD38XovFOlurg%3D 12438227
20. YF Hou ST Yuan HC Li J Wu JS Lu G Liu LJ Lu ZZ Shen J Ding ZM Shao 2004 ERbeta exerts multiple stimulative effects on human breast carcinoma cells Oncogene 23 5799 5806 10.1038/sj.onc.1207765 1:CAS:528:DC%2BD2cXmtVCnsLs%3D 15208676
21. A Howell J Cuzick M Baum A Buzdar M Dowsett JF Forbes G Hoctin-Boes J Houghton GY Locker JS Tobias ATAC Trialists' Group 2005 Results of the ATAC (Arimidex, Tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for breast cancer Lancet 365 60 62 10.1016/S0140-6736(05)74803-0 1:STN:280:DC%2BD2M%2FhsVartA%3D%3D 15639680
22. DR Hurst Y Xie KS Vaidya A Mehta BP Moore MA Accavitti-Loper RS Samant R Saxena AC Silveira DR Welch 2008 Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cells J Biol Chem 283 7438 7444 10.1074/jbc.M709446200 1:CAS:528:DC%2BD1cXjt1emuro%3D 18211900
23. A Keller AI Nesvizhskii E Kolker R Aebersold 2002 Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search Anal Chem 74 5383 5392 10.1021/ac025747h 1:CAS:528: DC%2BD38XmvVyktL4%3D 12403597
24. SK Kurdistani P Arizti CL Reimer MM Sugrue SA Aaronson SW Lee 1998 Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage Cancer Res 58 4439 4444 1:CAS:528:DyaK1cXmsVyqtrk%3D 9766676
25. P Lachat P Shaw S Gebhard N van Belzen P Chaubert FT Bosman 2002 Expression of NDRG1, a differentiation-related gene, in human tissues Histochem Cell Biol 118 399 408 10.1007/s00418-002-0460-9 1:CAS:528:DC%2BD38Xos1eltLk%3D 12432451
26. A Lal AE Lash SF Altschul V Velculescu L Zhang RE McLendon MA Marra C Prange PJ Morin K Polyak N Papadopoulos B Vogelstein KW Kinzler RL Strausberg GJ Riggins 1999 A public database for gene expression in human cancers Cancer Res 59 5403 5407 1:CAS:528:DyaK1MXnt1Gjtbo%3D 10554005
27. DQ Li L Wang F Fei YF Hou JM Luo Wei-Chen R Zeng J Wu JS Lu GH Di ZL Ou QC Xia ZZ Shen ZM Shao 2006 Identification of breast cancer metastasis- associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry Proteomics 6 3352 3368 10.1002/pmic.200500617 1:CAS:528:DC%2BD28Xmt1artL0%3D 16637015
28. M Li S Li Z Lou X Liao X Zhao Z Meng M Bartlam Z Rao 2008 Crystal structure of human transgelin J Struct Biol 162 229 236 10.1016/j.jsb.2008.01. 005 1:CAS:528:DC%2BD1cXlslGqtr0%3D 18291675
29. YF Liu ZQ Xiao MX Li MY Li PF Zhang C Li F Li YH Chen H Yi HX Yao ZC Chen 2009 Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma J Pathol 217 54 64 10.1002/path.2429 1:CAS:528: DC%2BD1MXhsVaru70%3D 18798225
30. XN Luo B Mookerjee A Ferrari S Mistry GF Atweh 1994 Regulation of phosphoprotein p18 in leukemic cells. Cell cycle regulated phosphorylation by p34cdc2 kinase J Biol Chem 269 10312 10318 1:CAS:528:DyaK2cXivFCrsLc%3D 8144611
31. RR Nair J Solway DD Boyd 2006 Expression cloning identifies transgelin (SM22) as a novel repressor of 92-kDa type IV collagenase (MMP-9) expression J Biol Chem 281 26424 26436 10.1074/jbc.M602703200 1:CAS:528:DC%2BD28XovFyqtbY%3D 16835221
32. AI Nesvizhskii A Keller E Kolker R Aebersold 2003 A statistical model for identifying proteins by tandem mass spectrometry Anal Chem 75 4646 4658 10.1021/ac0341261 1:CAS:528:DC%2BD3sXltlynt70%3D 14632076
33. S Nishio K Ushijima N Tsuda S Takemoto K Kawano T Yamaguchi N Nishida T Kakuma H Tsuda T Kasamatsu Y Sasajima M Kage M Kuwano T Kamura 2008 Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma Cancer Lett 264 36 43 10.1016/j.canlet. 2008.01.020 1:CAS:528:DC%2BD1cXls12ju7Y%3D 18281151
34. K Nylander U Marklund G Brattsand M Gullberg G Roos 1995 Immunohistochemical detection of oncoprotein 18 (Op18) in malignant lymphomas Histochem J 27 155 160 10.1007/BF00243911 1:STN:280:DyaK2M3ptlOjtQ%3D%3D 7775200
35. K Onoda FX Yu HL Yin 1993 gCap39 is a nuclear and cytoplasmic protein Cell Motil Cytoskelet 26 227 238 10.1002/cm.970260306 1:CAS:528: DyaK2cXhvVOrsL0%3D
36. TD Pollard GG Borisy 2003 Cellular motility driven by assembly and disassembly of actin filaments Cell 112 453 465 10.1016/S0092-8674(03)00120-X 1:CAS:528:DC%2BD3sXhs1SnsL0%3D 12600310
37. DK Price JR Ball Z Bahrani-Mostafavi JC Vachris JS Kaufman RW Naumann RV Higgins JB Hall 2000 The phosphoprotein Op18/stathmin is differentially expressed in ovarian cancer Cancer Invest 18 722 730 10.3109/07357900009012204 1:CAS:528:DC%2BD3cXos1Oqtr0%3D 11107442
38. JM Rae SJ Ramus M Waltham JE Armes IG Campbell R Clarke RJ Barndt MD Johnson EW Thompson 2004 Common origins of MDA-MB-435 cells from various sources with those shown to have melanoma properties Clin Exp Metastasis 21 543 552 10.1007/s10585-004-3759-1 1:CAS:528:DC%2BD2MXhtlKrtr0%3D 15679052
39. JM Rae CJ Creighton JM Meck BR Haddad MD Johnson 2007 MDA-MB-435 cells are derived from M14 melanoma cells-a loss for breast cancer, but a boon for melanoma research Breast Cancer Res Treat 104 13 19 10.1007/s10549-006-9392-8 17004106
40. S Rana PB Maples N Senzer J Nemunaitis 2008 Stathmin 1: a novel therapeutic target for anticancer activity Expert Rev Anticancer Ther 8 1461 1470 10.1586/14737140.8.9.1461 1:CAS:528:DC%2BD1cXhtVOhsr3E 18759697
41. M Renz B Betz D Niederacher HG Bender J Langowski 2008 Invasive breast cancer cells exhibit increased mobility of the actin-binding protein CapG Int J Cancer 122 1476 1482 10.1002/ijc.23215 1:CAS:528:DC%2BD1cXivVahsr8%3D 18059028
42. DC Rowlands A Williams NA Jones SS Guest GM Reynolds PC Barber G Brown 1995 Stathmin expression is a feature of proliferating cells of most, if not all, cell lineages Lab Invest 72 100 113 1:CAS:528:DyaK2MXltFChur8%3D 7837783
43. D Schunke P Span H Ronneburg A Dittmer M Vetter HJ Holzhausen E Kantelhardt S Krenkel V Müller FC Sweep C Thomssen J Dittmer 2007 Cyclooxygenase-2 is a target gene of rho GDP dissociation inhibitor beta in breast cancer cells Cancer Res 67 10694 10702 10.1158/0008-5472.CAN-07-1621 1:CAS:528:DC%2BD2sXhtlSls7vL 18006811
44. A Shevchenko M Wilm O Vorm M Mann 1996 Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels Anal Chem 68 850 858 10.1021/ac950914h 1:CAS:528:DyaK28XntlygtA%3D%3D 8779443
45. CC Thompson FJ Ashcroft S Patel G Saraga D Vimalachandran W Prime F Campbell A Dodson RE Jenkins NR Lemoine T Crnogorac-Jurcevic HL Yin E Costello 2007 Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motility Gut 56 95 106 10.1136/gut.2005.083691 1:CAS:528:DC%2BD2sXhtF2qsLY%3D 16847067
46. N Van Belzen WN Dinjens MP Diesveld NA Groen AC van der Made Y Nozawa R Vlietstra J Trapman FT Bosman 1997 A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms Lab Invest 77 85 92 9251681
47. PR Van Ginkel RL Gee TM Walker DN Hu CW Heizmann AS Polans 1998 The identification and differential expression of calcium-binding proteins associated with ocular melanoma Biochim Biophys Acta 1448 290 297 10.1016/S0167-4889(98)00133-5 9920419
48. B Weigelt JL Peterse LJ van 't Veer 2005 Breast cancer metastasis: markers and models Nat Rev Cancer 5 591 602 10.1038/nrc1670 1:CAS:528: DC%2BD2MXmvVCltrg%3D 16056258
49. JX Yan R Wait T Berkelman RA Harry JA Westbrook CH Wheeler MJ Dunn 2000 A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry Electrophoresis 21 3666 3672 10.1002/1522-2683(200011)21: 17<3666::AID-ELPS3666>3.0.CO;2-6 1:CAS:528:DC%2BD3cXos1SntL8%3D 11271485
50. Z Yang YJ Chang H Miyamoto J Ni Y Niu Z Chen YL Chen JL Yao PA di Sant'Agnese C Chang 2007 Transgelin functions as a suppressor via inhibition of ARA54-enhanced androgen receptor transactivation and prostate cancer cell growth Mol Endocrinol 21 343 358 10.1210/me.2006-0104 1:CAS:528:DC%2BD2sXhsVWisLs%3D 17082327